Abstract:BackgroundC type CpG oligodeoxynucleotides (CpG-C ODNs), possessing the features of both A type and B type CpG ODNs, exert a variety of immunostimulatory activities and have been demonstrated as an effective antitumor immunotherapy. Based on the structural characteristics, we designed 20 potential ODNs with the aim of synthesizing an optimal, novel CpG-C ODN specific to human and murine Toll-like receptor 9 (TLR9). We also sought to investigate the in vitro immunostimulatory and in vivo antitumor effects of the novel CpG-C ODN.MethodsTwenty potential CpG-C ODNs were screened for their ability to secrete interferon (IFN)-α, and interleukin (IL)-6 and tumor necrosis factor (TNF)-α production for the three most promising sequences were assayed in human peripheral blood mononuclear cells (PBMCs) by enzyme-linked immunosorbent assay (ELISA) or cytometric bead array assay. The functions of human and mouse B cells, and cytokine production in mice induced by the most promising sequence, HP06T07, were determined by flow cytometry and ELISA. Growth and morphology of tumor tissues in in vivo murine models inoculated with CT26 cells were analyzed by a growth inhibition assay and immunohistochemistry, respectively.ResultsAmong the 20 designed ODNs, HP06T07 significantly induced IFN-α, IL-6, and TNF-α secretion, and promoted B-cell activation and proliferation in a dose-dependent manner in human PBMCs and mouse splenocytes in vitro. Intratumoral injection of HP06T07 notably suppressed tumor growth and prolonged survival in the CT26 subcutaneous mouse model in a dose-dependent manner. HP06T07 administered nine times at 2-day intervals (I2) eradicated tumor growth at both primary and distant sites of CT26 tumors. HP06T07 restrained tumor growth by increasing the infiltration of T cells, NK cells, and plasmacytoid dendritic cells (pDCs).ConclusionsHP06T07, a novel CpG-C ODN, shows potent immunostimulatory activity in vitro and suppresses tumor growth in the CT26 subcutaneous mouse model.

Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9

Phosphorothioate modification of the TLR9 ligand CpG ODN inhibits poly(I:C)-induced apoptosis of hepatocellular carcinoma by entry blockade.

Toll-like Receptor 9 Activation by CpG Oligodeoxynucleotideï¿½7909 Enhances the Radiosensitivity of A549 Lung Cancer Cells Via the P53 Signaling Pathway

Targeting Toll-Like Receptor 9 with CpG Oligodeoxynucleotides Enhances Anti-Tumor Responses of Peripheral Blood Mononuclear Cells from Human Lung Cancer Patients.

Effects of CpG ODN on Dendritic Cells in Anti-Hepatocarcinoma Action

Functional Expression of TLR9 is Associated to the Metastatic Potential of Human Lung Cancer Cell

Inhibitory Effect of EGFR Antisense Oligodeoxynucleotide on Human Hepatoma Cell Line.

CpG Oligodeoxynucleotide Induces Apoptosis and Cell Cycle Arrest in A20 Lymphoma Cells Via TLR9-mediated Pathways

Toll-like Receptor Agonists Induce Apoptosis in Mouse B-cell Lymphoma Cells by Altering NF-κB Activation

CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials

TLR9 Signaling Promotes Tumor Progression of Human Lung Cancer Cell in Vivo

Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis.

CpG-ODN enhances sensitivity to chemotherapy in lung cancer cell line A549

Toll-Like Receptor 9 Agonist Inhibits Er Alpha-Mediated Transactivation by Activating Nf-Kappa B in Breast Cancer Cell Lines

Selective Up-Regulation of Cdk2 is Critical for Tlr9 Signaling Stimulated Proliferation of Human Lung Cancer Cell

CpG Oligonucleotides Suppress HepG2 Cells-Induced Jurkat Cell Apoptosis Via the Fas-FasL-mediated Pathway

CpG ODN Pretreatment Attenuates Concanavalin A-induced Hepatitis in Mice

Development of CpG oligodeoxynucleotide TLR9 agonists in anti-cancer therapy

ONTD Induces Apoptosis of Human Hepatoma Bel-7402 Cells Via a MAPK-dependent Mitochondrial Pathway and the Depletion of Intracellular Glutathione.

ONTD Induces Growth Arrest and Apoptosis of Human Hepatoma Bel-7402 Cells Though a Peroxisome Proliferator-Activated Receptor Γ-Dependent Pathway.

A Novel C Type CpG Oligodeoxynucleotide Exhibits Immunostimulatory Activity in Vitro and Enhances Antitumor Effect in Vivo